http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2133253-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34cd435dab366d2351454495963fba5f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
filingDate 1994-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8692f8866aef4b4bca2e00da449998f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_432832fc3c294b4e775964bc50fa5567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd010cb5de191470e1303c0b2e12ddb0
publicationDate 1999-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2133253-C1
titleOfInvention Purified heparin fraction, method of its preparing and pharmaceutical composition containing on said
abstract FIELD: medicine, pharmacy. SUBSTANCE: invention relates to heparins of the low-molecular mass obtained by nitrose depolymerization of the natural heparin and containing nitros compounds at amount less or equal to 5 x 10 -7 mg/mg product. For removal of nitros compounds an aqueous solution of low-molecular mass heparin is treated by ultraviolet rays (wavelength is from 180 to 350 nm) at temperature 5-50 C and pH 3-8. For preparing the purified low-molecular mass heparin an aqueous solution of the natural heparin sodium salt (concentration is 5-15 wt. -%/vol. ) is treated with alkaline metal nitrite as measured 1.5-6.9 wt.-% nitrite to heparin salt taken. The indicated reaction is carried out in the presence of hydrochloric acid at pH from 1 to 5 for time from 20 to 50 min up to negative test for nitro-ions. Obtained product is reduced by addition of sodium boron hydride at amount 0.5-2.0 wt. -% of heparin salt amount taken. An excess of boron hydride is decomposed with hydrochloric acid. Obtained reaction medium is neutralized and the low-molecular mass heparin is precipitated with ethanol as a sodium salt. An aqueous solution of the obtained sodium salt is treated by ultraviolet rays. For preparing nitros compound-containing product at amount less or equal to 5 x 10 -8 mg/mg product the solution treated by ultraviolet rays is fed additionally on anion-exchange column. The indicated column is washed out with water at pH about 7 and the end product is recuperated by precipitation with sodium chloride and ethanol. Pharmaceutical composition based on the low-molecular mass purified heparin shows antithrombosis activity. Method of purification of the low-molecular mass heparin from nitros compounds by ultraviolet irradiation ensures to retain its biological and physical-chemical properties. EFFECT: improved method of preparing. 17 cl, 2 tbl, 2 dwg, 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-186728-U1
priorityDate 1993-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423217529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22959485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86742833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451404211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452784088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454306093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25244225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28123
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4311764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414870324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 54.